Fractyl Health, Inc. (GUTS)
4.20
-0.03
(-0.71%)
USD |
NASDAQ |
Oct 09, 09:34
Fractyl Health Net Income (Quarterly) : -25.54M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.54M |
| March 31, 2026 | 9.218M |
| December 31, 2025 | -43.73M |
| September 30, 2025 | -45.60M |
| June 30, 2025 | -27.89M |
| March 31, 2025 | -23.74M |
| December 31, 2024 | -24.97M |
| September 30, 2024 | -23.17M |
| June 30, 2024 | -17.23M |
| March 31, 2024 | -3.322M |
| Date | Value |
|---|---|
| December 31, 2023 | -19.18M |
| September 30, 2023 | -15.75M |
| June 30, 2023 | -30.23M |
| March 31, 2023 | -11.93M |
| December 31, 2022 | -10.86M |
| September 30, 2022 | -11.06M |
| December 31, 2021 | -12.53M |
| September 30, 2021 | -9.13M |
| December 31, 2020 | -8.135M |
| September 30, 2020 | -7.384M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -6.284M |
| Spectral AI, Inc. | -4.176M |
| Vaxcyte, Inc. | -284.30M |
| Moderna, Inc. | -782.00M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.54M |
| EPS Diluted (Quarterly) | -1.932 |
| Enterprise Value | 69.52M |
| Earnings Yield | -312.4% |
| Normalized Earnings Yield | -242.01 |